If everything goes as planned, it may be approved by the FDA in 2026 or later
For diabetes management, tirzepatide is indicated as an adjunct to diet and exercise to improve glycemic control in adults
Many tirzepatide tablets sold online are unapproved products, and the FDA has publicly warned about safety, quality, counterfeit labeling, and dosing problems with unapproved GLP-1 drugs marketed for weight loss (FDA warning on unapproved GLP-1 drugs)
However, it is essential to consult a healthcare provider to determine if its suitable based on medical history, current health status, and weight loss goals
If you miss doses and approach the beyond-use date with significant medication remaining, consult your healthcare provider about whether to continue or obtain a fresh vial, and do not extend use beyond the assigned BUD